Discontinuing the recommendation of hip precautions does not increase the risk of early dislocation after primary total hip arthroplasty using 36-mm heads: a population-based study from the Danish Hip Arthroplasty Register

Afrim ILJAZI 1, Michala Skovlund SØRENSEN 1,2,5, Matilde WINTHER-JENSEN 3, Søren OVERGAARD 4,5, and Michael Mørk PETERSEN 1,5

1 Department of Orthopedic Surgery, Copenhagen University Hospital Rigshospitalet; 2 Department of Orthopedic Surgery, Zealand University Hospital; 3 Department of Data, Biostatistics and Pharmacoepidemiology, Centre for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg-Frederiksberg; 4 Department of Orthopedic Surgery and Traumatology, Copenhagen University Hospital Bispebjerg-Frederiksberg; 5 Department of Clinical Medicine, Faculty of Health Science, University of Copenhagen, Denmark

Background and purpose — Dislocation is a severe complication following total hip arthroplasty (THA). Hip precautions have been recommended in the initial postoperative period but evidence supporting this practice is limited. We therefore conducted a population-based study to evaluate the association between discontinuing recommending postoperative hip precautions and the risk of early dislocation.

Methods — This is a cohort study with data from the Danish Hip Arthroplasty Register and the Danish National Patient Register. We included patients who underwent primary THA for osteoarthritis in 2004–2019 in public hospitals in the Capital Region of Denmark. The cohort was divided into the hip precautions group, comprising patients operated on between 2004 and 2009, and the no-precautions group operated on between 2014 and 2019. The primary outcome was the difference in the absolute risk of dislocation within 3 months post-surgery. The secondary outcome assessed the same risk within 2 years. We evaluated the difference in absolute risk using absolute risk regression (ARR).

Results — The cumulative incidence of dislocation within 3 months was 2.9% (confidence interval [CI] 2.5–3.3) in the hip precautions group and 3.5% (CI 3.1–3.9) in the no-precautions group. The risk of dislocation was higher in the no-precautions group but failed to reach statistical significance in the crude (ARR 1.2, CI 0.9–1.6) and multivariate model (ARR 1.4, CI 0.9–2.2).

Conclusion — We found a higher but statistically insignificant increase in the risk of early dislocation in the no-precautions group. The lack of significance in the association may be explained by the increased use of 36-mm femoral heads after the guideline revision.

 

Citation: Acta Orthopaedica 2024; 95: 407–414. DOI: https://doi.org/10.2340/17453674.2024.41168.

Copyright: © 2024 The Author(s). Published by MJS Publishing – Medical Journals Sweden, on behalf of the Nordic Orthopedic Federation. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits sharing, adapting, and using the material for any purpose, including commercial use, with the condition of providing full attribution to the original publication.

Submitted: 2024-03-28. Accepted: 2024-07-03. Published: 2024-07-18.

Correspondence: afrim.iljazi.04@regionh.dk

AI: design of the study, data analysis, interpretation of the results, writing of the original draft, critical revisions, and funding acquisition. MSS: design of the study, supervision, interpretation of the results, and critical revisions of the manuscript. MW-J: data analysis, supervision, interpretation of the results, and critical revisions of the manuscript. SO: design of the study, interpretation of the results, and critical revisions of the manuscript. MMP: conceptualization and design of the study, interpretation of the results, critical revisions of the manuscript, and funding acquisition.

Handling co-editors: Bart A. Swierstra and Philippe Wagner

Acta thanks Ian Harris and Matthijs P Somford for help with peer review of this manuscript.

 

Dislocation following total hip arthroplasty (THA) is the primary reason for revision surgery, accounting for about 20% of revisions [1,2]. Notably, nearly half of the patients with dislocations require revision within 2 years, compared with less than 2% without dislocations [3]. Furthermore, patients revised for recurrent dislocations are at increased risk of further dislocations and revisions, leading to significant health-economic costs [1,4]. Reducing dislocation risk is therefore essential. Traditional postoperative guidelines recommended limiting hip flexion, adduction, and internal rotation [5]. These guidelines lacked robust clinical evidence, despite being biomechanically meaningful [6-8]. Until June 2012, the Capital Region of Denmark’s postoperative guidelines following THA mandated hip precautions. However, studies indicated no increased dislocation rates in THA using anterior/anterolateral approaches without these precautions [9-11]. Consequently, in June 2012, the guidelines were revised to eliminate the hip precaution recommendation. Using this change in our guidelines for precautions in the Capital Region of Denmark, we performed a study with data from the Danish Hip Arthroplasty Register (DHR) and the Danish National Patient Register (DNPR), which covers all public hospitals in the Capital Region. We aimed to determine the association between the removal of hip precautions from regional postoperative guidelines and the risk of early postoperative dislocation.

Methods

Study design and setting

The study is reported in accordance with the RECORD guidelines [12]. The current study is a population-based cohort study drawing on prospectively collected data from the DHR and the DNPR. The DHR is a register that collects data on THAs and their subsequent revisions [13]. As of 2021, the DHR has a completeness rate of 97% for primary THAs and 95% for revisions [2]. The DNPR is an administrative database that captures all hospital contacts, including the discharge diagnoses for each contact [14]. All Danish inhabitants possess a unique 10-digit civil registration number, which facilitates linkage across administrative databases.

Study population

The cohort was sourced from the DHR based on the following criteria: primary/idiopathic osteoarthritis (OA) diagnosis in patients who underwent THA at public hospitals in the Capital Region of Denmark from January 1, 2004, to December 31, 2019, and resided in Denmark at the time of surgery. Denmark is administratively divided into 5 healthcare regions. The study is limited only to patients from the Capital Region, as this is where the guideline was relevant. Moreover, inclusion was limited to surgeries with the posterior approach, representing over 97% of THAs in Denmark [4], and to patients with femoral head sizes of 28, 32, or 36 mm, the most commonly used sizes. We excluded patients treated at Rigshospitalet, where postoperative hip precautions were advised, patients under 40 years and patients undergoing revision surgery, patients receiving constrained liners or metal-on-metal implants, had unspecified laterality or surgical approach, or received reverse-hybrid cemented prostheses. The follow-up period was 2 years, with censoring at the first occurrence of dislocation, implant removal, death, or emigration. We considered only the first THA for patients with bilateral surgery.

Outcomes and variables

The Capital Region of Copenhagen previously endorsed specific hip precautions advising against hip flexion exceeding 90°, adduction beyond the midline, and cautioned against internal rotation for the initial 12 weeks after the surgery. A revision of the guideline on June 29, 2012 eliminated these precautions, advocating instead for patient-guided mobilization within individual comfort zones. Dislocations were identified in the DNPR using a validated algorithm with a sensitivity of 91% and a positive predictive value of 93% [15] (Case definitions, see Appendix). The primary outcome assessed the difference in the absolute risk of dislocation within 3 months between the hip precautions and no-precautions groups. The secondary outcome evaluated the same parameter within 2 years. We retrieved demographic and surgical data, including age, sex, year of surgery, and implant specifics, from the DHR. The comorbidities dementia, history of alcohol abuse, lumbar spinal fusion, neurological motor dysfunction, and the outcome dislocation were identified through the DNPR. The study population is stratified in 2 cohorts: the hip precautions group and the no-precautions group. Some hospitals in the Capital Region abandoned hip precautions as early as 2010. For this reason, we designated patients operated on from January 1, 2004, to December 31, 2009 as the hip precautions group, marking the last known universal recommendation of hip precautions across the Capital Region. We defined the no-precautions group as patients operated on from January 1, 2014 to December 31, 2019, to ensure guideline implementation in clinical practice.

Statistics

We report categorical variables as frequencies and percentages and continuous variables as means and standard deviations (SD). In compliance with restrictions on use of register data, we do not present results when numbers are ≤ 3. The χ2-test was used to evaluate differences in categorical variables while Welch’s t-test was used on continuous variables. Competing risk analysis with the Aalen–Johnson estimator was performed to estimate the cumulative incidence of dislocation with 95% confidence intervals (CI) up to 2 years, considering implant removal and death as competing risks. Absolute risk regression (ARR) was used to estimate the difference in dislocation risk in the no-precautions group compared with the hip precautions group [16]. This was assessed with 3 models: (i) crude estimate, (ii) adjusted for femoral head size alone, and (iii) adjusted for femoral head size, age, sex, fixation, and the comorbidities dementia, lumbar spinal fusion, alcohol abuse, and neurological motor dysfunction. We did not include body mass index (BMI) in our analysis as data on height and weight was missing for 75% of patients, with a majority missing for patients undergoing surgery in the early period. A sensitivity analysis was performed where the cut-off time for group designation was set to the date of practice change in departments that abandoned hip precautions before June 2012, or June 29, 2012 for those departments where the exact date was unknown. The detailed results from the sensitivity analysis are presented in Table 5 (see Appendix). P < 0.05 is considered significant. All data analyses were conducted in R version 4.3.1 (R Foundation for Statistical Computing, Vienna, Austria) [17]. Competing risk analysis was performed with the Prodlim package [18], while ARR was conducted with the riskRegression package [19].

Ethics, registration, data sharing, funding, AI use, and disclosures

The Data Protection Agency of the Capital Region of Denmark approved this study (P-2022-717). Sharing of raw data from this study is not possible. Ethical approval of register studies is not required in Denmark. All data was handled via an encrypted server hosted by Statistics Denmark, where data was anonymized. Observations representing ≤ 3 individuals are not allowed to be reported due to restrictions on the use of register data. Rigshospitalet’s Research Fund (in Danish: Rigshospitalets Forskningspulje) provided funding for the study with a grant to cover the salary of 1 PhD student (AI). Kong Christian den Tiendes Fond has supported this study with a grant of DKK 50,000 for statistical assistance. The authors have no conflicts of interest to declare. The authors disclose that ChatGPT, GPT-4 (OpenAI) has been used to edit spelling and grammar as well as improving the readability and language of this manuscript. Complete disclosure of interest forms according to ICMJE are available on the article page, doi: 10.2340/17453674.2024.41168

Results

Baseline data

5,769 patients were classified into the hip precautions group, while 9,030 patients were included in the no-precautions group (Figure). Mean ages were 71 (SD 9.3) and 70 (SD 9.7) years, respectively, with females constituting 66% and 62%. The use of uncemented prostheses increased from 54% to 85% in the no-precautions group. Dementia, history of alcohol abuse, neuromuscular dysfunction, and previous lumbar spinal fusion was more prevalent in the no-precautions group (Table 1). There was a shift in femoral head sizes used. The most common size was 28 mm, used in 67% in the hip precautions group, while 23% received 32-mm heads and only 10% received 36-mm heads. In contrast, 73% received 36-mm heads in the no-precautions group, while 26% received 32-mm heads, and only 85 patients received 28-mm heads (Table 1). In patients with comorbidities, there was a trend towards use of 36-mm heads in the no-precautions group, compared with 28-mm and 32-mm heads in the hip precautions group (Table 2, see Appendix).

Table 1. Baseline characteristics for patients in the 2 groups. Results are presented as mean (standard deviation) for age as a continuous variable and number (%) for the remaining variables
Factor Hip precautions n = 5,769 No precautions n = 9,030 P value
Age 71 (9.3) 70 (9.7) <0.001
Age group <0.001
 < 65 years 1,474 (26) 2,500 (28)
 65–75 years 2,247 (39) 3,686 (41)
 > 75 years 2,048 (36) 2,844 (32)
Alive after 2 years 5,541 (96) 8,801 (98) <0.001
Sex <0.001
 Female 3,828 (66) 5,565 (62)
 Male 1,968 (34) 3,465 (38)
Fixation <0.001
 Cemented 1,101 (19) 480 (5)
 Uncemented 3,115 (54) 7,680 (85)
 Hybrid 1,553 (27) 870 (10)
Femoral head <0.001
 28 mm 3,842 (67) 85 (1)
 32 mm 1,347 (23) 2,335 (26)
 36 mm 580 (10) 6,610 (73)
Comorbidities
 Dementia 36 (0.6) 33 (0.4) 0.03
 Lumbar fusion 62 (1.1) 134 (1.5) 0.04
 Alcohol abuse 70 (1.2) 175 (1.9) 0.001
 NMD 39 (0.7) 114 (1.3) 0.001
NMD = neurologic motor dysfunction.

Figure 1
Flowchart of the study inclusion process.

Cumulative incidence of dislocation

The cumulative incidence of dislocation was 2.9% (CI 2.5–3.3) at 3 months and 5.5% (CI 4.9–6.0) at 2 years for the hip precautions group and 3.5% (CI 3.1–3.9) and 5.0% (CI 4.5–5.4), respectively, in the no-precautions group (Table 3). The highest dislocation rates were in patients with 28-mm heads: 3.0% (CI 2.5–6.0) and 5.8% (CI 5.0–6.5) in the hip precautions group, and 5.9% (CI 0.9–10.9) and 7.1% (CI 1.6–12.5) in the no-precautions group at 3 months and 2 years, respectively. For 32-mm heads, the results were 2.5% (CI 1.7–3.4) and 5.0% (CI 3.9–6.2) in the hip precautions group, and 4.9% (CI 5.0–5.8) and 6.3% (CI 5.3–7.3) in the no-precautions group. The lowest rates were for 36-mm heads: 2.8% (CI 1.4–4.1) and 4.3% (CI 2.7–6.0) in the hip precautions group, and 3.0% (CI 2.6–3.4) and 4.5% (4.0–5.0) in the no hip precautions group (Table 3).

Table 3. Cumulative incidence of dislocation overall and stratified by femoral head size
Femoral head Precautions 0 to 3 months 3 months to 2 years
At risk Events Cumulative incidence (CI) At risk Events Cumulative incidence (CI)
Overall Yes 5,769 166 2.9 (2.5–3.3) 5,367 73 5.5 (4.9–6.0)
No 9,030 317 3.5 (3.1–3.9) 8,424 61 5.0 (4.5–5.4
28 mm Yes 3,842 116 3.0 (2.5–3.6) 3,569 54 5.8 (5.0–6.5)
No 85 ≤ 5 5.9 (0.9–10.9) 76 ≤ 5 7.1 (1.6–12.5)
32 mm Yes 1,347 34 2.5 (1.7–3.4) 1,257 15 5.0 (3.9–6.2)
No 2,335 114 4.9 (4.0–5.8) 2,129 17 6.3 (5.3–7.3)
36 mm Yes 580 16 2.8 (1.4–4.1) 541 ≤5 4.3 (2.7–6.0)
No 6,610 198 3.0 (2.6–3.4) 6,219 44 4.5 (4.0–5.0)

Risk of dislocation before and after implementation of the guideline change

We found a slightly increased risk of early dislocation in the no-precautions group; however, this increase failed to reach statistical significance (Table 4). The crude model showed an increase in the no-precautions group within 3 months that did not reach significance (ARR 1.2, CI 0.9–1.6), while there was no difference within 2 years (ARR 1.0, CI 0.8–1.3). A model adjusting only for femoral head size indicated a higher dislocation risk in the no-precautions group at 3 months (ARR 1.7, CI 1.1–2.6) and 2 years (ARR 1.4, CI 1.0–1.9). However, the full model, accounting for demographics, fixation, and comorbidities, showed no significant association within either 3 months (ARR 1.4, CI 0.9–2.2) or 2 years (ARR 1.2, CI 0.9–1.7) (Table 4). The sensitivity analysis, extending the study period to include 2010–2014, aligned with the primary findings (Table 5, see Appendix). The crude model’s ARR was 1.2 (CI 0.9–1.7) at 3 months and 1.1 (CI 0.9–1.4) at 2 years. The full model showed an ARR of 1.3 (CI 1.0–1.9; P = 0.08) at 3 months and 1.2 (CI 0.9–1.5) at 2 years.

Table 4. Absolute risk regression (ARR) with 95% confidence intervals (CI) for the primary outcome (3 months) and secondary outcome (2 years). Table includes the crude model, the model adjusted only for femoral head and the full model adjusted for femoral head, age, sex, fixation and history of dementia, lumbar spinal fusion, alcohol abuse, and neurologic motor dysfunction (NMD)
Model 3 months 2 years
Factor ARR (CI) P value ARR (CI) P value
Crude model
 Hip precautions Ref. Ref.
 No hip precautions 1.2 (0.9–1.6) 0.3 1.0 (0.8–1.3) 1
Adjusted for femoral head alone
 Hip precautions Ref. Ref.
 No hip precautions 1.7 (1.1–2.6) 0.01 1.4 (1.0–1.9) 0.04
 32 mm Ref. Ref.
 28 mm 1.1 (0.8–1.7) 0.5 1.1 (0.8–1.5) 0.5
 36 mm 0.65 (0.5–0.8) < 0.001 0.7 (0.6–0.8) < 0.001
Full model
 Hip precautions Ref. Ref.
 No hip precautions 1.4 (0.9–2.2) 0.1 1.2 (0.9–1.7) 0.2
 32 mm Ref. Ref
 28 mm 0.9 (0.6–1.3) 0.6 1.0 (0.8–1.4) 0.8
 36 mm 0.6 (0.4–0.8) < 0.001 0.7 (0.5–0.9) 0.002
 Age 65–75 Ref. Ref.
 Age < 65 0.8 (0.6–1.0) 0.04 0.8 (0.6–1.0) 0.02
 Age > 75 1.3 (1.1–1.6) 0.002 1.3 (1.1–1.6) 0.001
 Female sex Ref. Ref.
 Male sex 1.4 (1.1–1.7) 0.004 1.0 (0.9–1.3) 0.6
 Cemented Ref. Ref.
 Uncemented 1.6 (1.0–2.4) 0.04 1.2 (0.9–1.7) 0.2
 Hybrid cemented 1.5 (1.0–2.2) 0.08 1.1 (0.8–1.6) 0.4
 Dementia 3.9 (1.9–7.9) < 0.001 2.5 (1.3–4.8) 0.007
 Lumbar fusion 1.5 (0.8–3.0) 0.3 2.3 (1.5–3.6) < 0.001
 Alcohol abuse 1.3 (0.7–2.3) 0.4 2.4 (1.6–3.7) < 0.001
 NMD 0.7 (0.3–1.7) 0.5 0.4 (0.7–2.6) 0.4

Discussion

We aimed to assess whether omitting the recommendation for hip precautions from the regional guideline on postoperative mobilization following THA increased the risk of early dislocation. Contrary to our hypothesis, the study did not find a clear association between discontinuing the recommendation for hip precautions and the risk of early dislocation within 3 months or 2 years. Secondary analysis accounting solely for femoral head size showed an increased dislocation risk in the no-precautions group, suggesting a protective effect of hip precautions in patients receiving 28-mm and 32-mm femoral heads. However, after also accounting for age, sex, fixation, and comorbidities in the full model, the removal of hip precautions from the guideline again failed to reach significance for an increased dislocation risk. Our findings imply that the elevated dislocation risk in certain patients is mitigated by using larger femoral heads, thus questioning the necessity of hip precautions in patients receiving THA with femoral heads ≥36 mm.

Comparison with current literature

Hip precautions have traditionally been advocated in the early phase after THA to mitigate early dislocation risk [6]. However, the scientific basis for persistently recommending these precautions has been questionable [7,8], with studies on patients receiving THA with the anterior/anterolateral approach finding no benefits of hip precautions [9-11]. In Denmark, the posterior approach, which is associated with a higher dislocation risk [19], is predominantly used [2], leading to suggestions that hip precautions could be beneficial in these cases. Existing clinical studies have not demonstrated any advantage of hip precautions in decreasing early dislocation risk for the posterior approach [20]. However, a common limitation across these studies is their design; most are single-center observational studies or small trials, which are underpowered due to the limited number of participants. Our population-based analysis, which exclusively included patients undergoing the posterior approach, supports previous findings that show no heightened risk when recommendations for hip precautions are omitted. Our findings are consistent with those from a similar study using a national administrative dataset from England [21]. Nonetheless, it is crucial to consider our results within the context of a rising proportion of patients receiving THA with 36-mm femoral heads, alongside concurrent advancements and heightened awareness in surgical techniques. Over time, there has been greater attention to factors known to decrease dislocation risk, such as cup positioning and meticulous capsular repair. These factors might have been more prevalent in the no-precautions group, who underwent surgery later compared with the hip precautions group [22,23].

High-risk patients and large-diameter femoral heads

We observed a higher proportion of patients with risk factors for dislocation in the no-precautions group, indicating a shift in the patient demographics of OA undergoing THA. Notably, there was an increased prevalence of neurologic motor dysfunction, prior lumbar spinal fusion surgery, and uncemented THA in the no-precautions group, which are known risk factors for dislocation [4,19]. These differences likely influenced the results of our ARR model that considers only femoral head size, as the disparities were not significant once we adjusted for comorbidities, fixation, and femoral head size. In the no-precautions group, a majority were fitted with 36-mm femoral heads, contrasting with a minority in the hip precautions group. Large-diameter femoral heads correlate with lower dislocation rates among high-risk patients [24,25]. Notably, 36-mm femoral heads are recognized for reducing dislocation compared with their 32-mm counterparts, with added efficacy in patients undergoing THA with the posterior approach [24,25]. Consequently, the potential negative impacts linked to discontinuing hip precautions are likely offset by the augmented adoption of large-diameter femoral heads.

Hip precautions and compliance

Our study uses the guideline’s inclusion of hip precautions as proxy for effectiveness of precautions. Our design is not able to assess the direct impact of the implementation of hip precautions, patient adherence, or healthcare practitioners’ compliance with guideline recommendations and subsequent omissions: 1 study evaluating hip precautions revealed that about 25% of patients in the hip precautions group did not adhere, while 20% in the no-precautions group followed some precautions unintentionally [26]. Additionally, 1 study on compliance found only 23% adhered to precautions after 6 weeks, despite 86% believing they could recall them [27], while another reported a mere 6% maintained restrictions for the full recommended timespan of 12 weeks [28]. Qualitative research shows challenges among healthcare providers, including doctors and nurses, in adapting to new protocols [29,30]. Difficulty in breaking from established routines leads to occasional reversion to old practices of recommending precautions, despite the official removal of these [29]. Communication inconsistencies also arise due to non-adherence to updated protocols by some colleagues or lack of awareness among external post-discharge therapists [29]. Furthermore, some continue to advise precautions for at-risk patients despite changes in practice guidelines [30].

Strengths and limitations

The main strengths of our study lie in its population-based design and linkage with the DNPR, facilitating the inclusion of data on comorbidities and hip dislocations. The latter was identified using a validated algorithm with an excellent sensitivity and positive predictive value [15]. Our study has certain limitations that need to be addressed. Despite an 18-month period for the adoption of the new guideline, the risk of incomplete implementation remains. We were unable to assess individual compliance, the degree of adherence to precautions, or the other pitfalls mentioned in the previous paragraph, as neither DHR nor DNPR records such information. Additionally, group allocation was based on a time cut-off, not randomization. Our analysis assumes that the guideline change was the primary factor influencing early dislocation risk. To mitigate other variables, we incorporated patient, surgical, and implant characteristics into an adjusted model. Nevertheless, the potential for residual confounding cannot be discounted, as there are other factors relevant for dislocation that we could not account for, either due to a lack of reporting in the databases such as whether or not capsular repair was performed, or due to a significant amount of missing data such as for BMI. It is worthwhile noting that we consistently found a higher dislocation risk in the no-precautions group even though these findings generally failed to reach significance, which is why our study does not clearly exclude the possibility that hip precautions could be of importance for certain patients.

Conclusion

We did not find a clear association between discontinuing the recommendation for hip precautions and the risk of early dislocation within 3 months or 2 years. There may be a potential role for hip precautions in patients receiving 28-mm or 32-mm femoral heads and in certain high-risk patients but not in patients with ≥ 36 mm heads.

  1. Bozic K J, Kamath A F, Ong K, Lau E, Kurtz S, Chan V, et al. Comparative epidemiology of revision arthroplasty: failed THA poses greater clinical and economic burdens than failed TKA. Clin Orthop Relat Res 2015; 473(6): 2131-8. doi: 10.1007/s11999-014-4078-8.
  2. Danish Hip Arthroplasty Register. National Annual Report. 2021. http://danskhoftealloplastikregister.dk/wp-content/uploads/2022/07/DHR-aarsrapport-2021_Udgivet-2022_offentliggjort-version.pdf.
  3. Gillinov S M, Joo P Y, Zhu J R, Moran J, Rubin L E, Grauer J N. Incidence, timing, and predictors of hip dislocation after primary total hip arthroplasty for osteoarthritis. J Am Acad Orthop Surg 2022; 30(21): 1047-53. doi: 10.5435/JAAOS-D-22-00150.
  4. Hermansen L L, Viberg B, Overgaard S. Risk factors for dislocation and re-revision after first-time revision total hip arthroplasty due to recurrent dislocation: a study from the Danish Hip Arthroplasty Register. J Arthroplasty 2021; 36(4): 1407-12. doi: 10.1016/j.arth.2020.10.004
  5. Woo R Y, Morrey B F. Dislocations after total hip arthroplasty. J Bone Joint Surg Am 1982; 64(9): 1295-306. PMID: 7142237.
  6. Nadzadi M E, Pedersen D R, Yack H J, Callaghan J J, Brown T D. Kinematics, kinetics, and finite element analysis of commonplace maneuvers at risk for total hip dislocation. J Biomech 2003; 36(4): 577-91. doi: 10.1016/s0021-9290(02)00232-4.
  7. Tejwani N C, Immerman I. Myths and legends in orthopaedic practice: are we all guilty? Clin Orthop Relat Res 2008; 466(11): 2861-72. doi: 10.1007/s11999-008-0458-2.
  8. Husted H, Gromov K, Malchau H, Freiberg A, Gebuhr P, Troelsen A. Traditions and myths in hip and knee arthroplasty. Acta Orthop 2014; 85(6): 548-55. doi: 10.3109/17453674.2014.971661.
  9. Talbot N J, Brown J H M, Treble N J. Early dislocation after total hip arthroplasty: are postoperative restrictions necessary? J Arthroplasty 2002;17(8):1006-8. doi: 10.1054/arth.2002.34534.
  10. Ververeli P A, Lebby E B, Tyler C, Fouad C. Evaluation of reducing postoperative hip precautions in total hip replacement: a randomized prospective study. Orthopedics 2009; 32(12): 889. doi: 10.3928/01477447-20091020-09.
  11. Restrepo C, Mortazavi S M J, Brothers J, Parvizi J, Rothman R H. Hip dislocation: are hip precautions necessary in anterior approaches? Clin Orthop Relat Res 2011; 469(2): 417-22. doi: 10.1007/s11999-010-1668-y.
  12. Benchimol E I, Smeeth L, Guttmann A, Harron K, Moher D, Peteresen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement. PLOS Med. 2015; 12(10): e1001885. doi: 10.1371/journal.pmed.1001885.
  13. Gundtoft P H, Varnum C, Pedersen A B, Overgaard S. The Danish Hip Arthroplasty Register. Clin Epidemiol 2016; 8: 509-14. doi: 10.2147/CLEP.S99498.
  14. Schmidt M, Schmidt SAJ, Sandegaard J L, Ehrenstein V, Pedersen L, Sørensen H T. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 2015; 7: 449-90. doi: 10.2147/CLEP.S91125.
  15. Hermansen L L, Viberg B, Overgaard S. Development of a diagnostic algorithm identifying cases of dislocation after primary total hip arthroplasty-based on 31,762 patients from the Danish Hip Arthroplasty Register. Acta Orthop 2021; 92(2): 137-42. doi: 10.1080/17453674.2020.1868708.
  16. Gerds T A, Ohlendorff S, Ozenne B. riskRegression: Risk regression models and prediction scores for survival analysis with competing risks. 2023. https://cran.r-project.org/package=riskRegression.
  17. R Core Team. R: A language and environment for statistical computing. 2023. https://www.r.project.org/.
  18. Gerds T. prodlim: Product-limit estimation for censored event history analysis. 2023. https://cran.r-project.org/package=prodlim.
  19. Kunutsor S K, Barrett M C, Beswick A D, Judge A, Blom A W, Wylde V, et al. Risk factors for dislocation after primary total hip replacement: meta-analysis of 125 studies involving approximately five million hip replacements. Lancet Rheumatol 2019; 1(2): e111-21. doi: 10.1016/s2665-9913(19)30045-1.
  20. Korfitsen C B, Mikkelsen L R, Mikkelsen M-L, Rohde J F, Holm P M, Tarp S, et al. Hip precautions after posterior-approach total hip arthroplasty among patients with primary hip osteoarthritis do not influence early recovery: a systematic review and meta-analysis of randomized and non-randomized studies with 8,835 patients. Acta Orthop 2023; 94: 141-51. doi: 10.2340/17453674.2023.11958.
  21. Machin J T, Gray W K, Roberts A, Kenworthy L, Manktelow A R J, Briggs T W R. An analysis of a national administrative dataset demonstrating no evidence of increase in elective primary total hip arthroplasty dislocation rates when postoperative hip precautions are not used. J Arthroplasty 2022; 37(12): 2365-73 doi: 10.1016/j.arth.2022.05.040.
  22. Hernandez N M, Steele J R, Wu C J, Cunningham D J, Aggrey G K, Bolognesi M P, et al. A specific capsular repair technique lowered early dislocations in primary total hip arthroplasty through a posterior approach. Arthroplast Today 2020; 6(4): 813-8. doi: 10.1016/j.artd.2020.07.044.
  23. Prietzel T, Hammer N, Schleifenbaum S, Adler D, Pretzsch M, Köhler L, et al. Der Einfluss der Kapselrekonstruktion auf die Luxationsrate nach primärer Hüftendoprothetik: eine retrospektive Analyse von 1972 Fällen [The impact of capsular repair on the dislocation rate after primary total hip arthroplasty: a retrospective analysis of 1972 cases]. Z Orthop Unfall 2014; 152(2): 130-43 [in German]. doi: 10.1055/s-0034-1368209.
  24. Zijlstra W P, De Hartog B, Van Steenbergen L N, Scheurs B W, Nelissen R G H H. Effect of femoral head size and surgical approach on risk of revision for dislocation after total hip arthroplasty. Acta Orthop 2017; 88(4): 395-401. doi: 10.1080/17453674.2017.1317515.
  25. van Steenbergen L N, de Reus I M, Hannink G, Vehmeijer S B, Schreurs B W, Zijlstra W P. Femoral head size and surgical approach affect dislocation and overall revision rates in total hip arthroplasty: up to 9-year follow-up data of 269,280 procedures in the Dutch Arthroplasty Register (LROI). Hip Int 2023; 33(6): 1056-62. doi: 10.1177/11207000231160223.
  26. Tetreault M W, Akram F, Li J, Nam D, Gerlinger T L, Della Valle C J, et al. Are postoperative hip precautions necessary after primary total hip arthroplasty using a posterior approach? Preliminary results of a prospective randomized trial. J Arthroplasty 2020; 35(6S): S246-51. doi: 10.1016/j.arth.2020.02.019.
  27. Lee G R H, Berstock J R, Whitehouse M R, Blom A W. Recall and patient perceptions of hip precautions 6 weeks after total hip arthroplasty. Acta Orthop 2017; 88(5): 496-9. doi: 10.1080/17453674.2017.1350008.
  28. McNaught J, Davidson D, Ewen A, Welsh F, Maheshwari R. Patient compliance with hip precautions 12 weeks following primary elective total hip arthroplasty. Arch Orthop Trauma Surg 2021; 142(10): 2429-33. doi: 10.1007/s00402-021-03837-9.
  29. Lightfoot C J, Coole C, Sehat K, Brewin C, Drummond A. Clinicians’ experiences of discontinuing routine hip precautions following total hip replacement surgery: a qualitative analysis. Disabil Rehabil 2022; 44(16): 4227-32. doi: 10.1080/09638288.2021.1884759.
  30. Mandel R T, Bruce G, Moss R, Carrington R W J, Gilbert A W. Hip precautions after primary total hip arthroplasty: a qualitative exploration of clinical reasoning. Disabil Rehabil 2022; 44(12): 2842-8. doi: 10.1080/09638288.2020.1845825.

Appendix

Case definitions

Primary total hip arthroplasty due to primary osteoarthritis

The patient cohort was sourced from the Danish Hip Arthroplasty Register (DHR), which exclusively records total hip arthroplasties (THA). To identify patients who underwent primary THA with osteoarthritis as the underlying condition, data was filtered using the criteria “Primary (idiopathic) arthrosis” under the “Underlying condition” column and “Primary surgery” under the “Surgery group” column, denoted by OGRUNDL = 1 & opgrp = “Primær”.

Dislocation

Dislocations were identified in the Danish National Patient Register (DNPR) using ICD-10 codes and/or NOMESCO procedure codes and classified as either true dislocations or probable dislocations as defined by Hermansen et al. [15]. The dislocation rate reported in this article is the first occurrence of either a true or a probable dislocation:

Comorbidities

The presence of a comorbidity was defined as at least one in-hospital or outpatient administrative contact preceding the date of the primary surgery with one of the following ICD-10 diagnosis or NOMESCO procedure code:

 

Table 2. Distribution of femoral head size by each comorbidity. Results are presented as the number (%) receiving a femoral head of either 28 and 32 mm or 36 mm of the total number of patients with each comorbidity stratified by group
Comorbidity Hip precautions No precautions
28 and 32 mm 36 mm 28 and 32 mm 36 mm
Dementia NP NP 13 (40) 20 (60)
Lumbar fusion 56 (90) 6 (10) 40 (30) 94 (70)
Alcohol abuse 61 (87) 9 (13) 43 (25) 132 (75)
NMD NP NP 44 (39) 70 (61)
NP = Not presented due to restrictions on use of register data.
NMD = neurologic motor dysfunction

 

Table 5. Sensitivity analysis where the cut-off period was extended to encompass the years 2010–2014 (see Methods section). Table presents the sensitivity analysis for the absolute risk regression (ARR) with 95% confidence intervals (CI) for the primary outcome (3 months) and secondary outcome (2 years). Table includes the crude model, the model adjusted only for femoral head, and the full model adjusted for femoral head, age, sex, fixation, and history of dementia, lumbar spinal fusion, alcohol abuse, and neurologic motor dysfunction (NMD)
Model 3 months 2 years
Factor ARR (CI) P value ARR (CI) P value
Crude model
 Hip precautions Ref. Ref.
 No hip precautions 1.2 (0.9–1.7) 0.2 1.1 (0.9–1.4) 0.4
Adjusted for femoral head alone
 Hip precautions Ref. Ref.
 No hip precautions 1.5 (1.1–2.1) 0.01 1.4 (1.1–1.7) 0.02
 32 mm Ref. Ref.
 28 mm 1.0 (0.8–1.4) 0.8 1.1 (0.9–1.4) 0.4
 36 mm 0.6 (0.6–0.9) < 0.001 0.7 (0.6–0.8) < 0.001
Full model
 Hip precautions Ref. Ref.
 No hip precautions 1.3 (1.0–1.9) 0.08 1.2 (0.9–1.5) 0.2
 32 mm Ref. Ref.
 28 mm 0.9 (0.7–1.3) 0.6 1.0 (0.8–1.3) 1
 36 mm 0.6 (0.5–0.8) < 0.001 0.7 (0.6–0.8) < 0.001
 Age 65–75 Ref. Ref.
 Age < 65 0.7 (0.6–0.9) 0.004 0.8 (0.6–0.9) < 0.001
 Age > 75 1.5 (1.2–1.7) < 0.001 1.4 (1.2–1.6) < 0.001
 Female sex Ref. Ref.
 Male sex 1.3 (1.1–1.5) < 0 .001 1.0 (0.9–1.2) 0.7
 Cemented Ref. Ref.
 Uncemented 1.9 (1.3–2.7) < 0.001 1.5 (1.1–1.9) 0.007
 Hybrid cemented 1.6 (1.1–2.4) 0.008 1.3 (1.0–1.7) 0.1
 Dementia 3.0 (1.5–5.9) < 0.001 2.5 (1.4–4.3) < 0.001
 Lumbar fusion 1.6 (0.9–2.9) 0.09 2.2 (1.4–3.3) < 0.001
 Alcohol abuse 2.0 (1.3–3.0) 0.002 2.8 (1.9–3.9) < 0.001
 NMD 1.3 (0.8–2.4) 0.3 1.7 (1.1–2.7) < 0.001